NCT06355570 (DaCsi-ICU) is a NA clinical trial of Personal Pictures in Intensive Care Unit Delirium, sponsored by Imperial College Healthcare NHS Trust.

Who is sponsoring NCT06355570?

NCT06355570 is sponsored by Imperial College Healthcare NHS Trust.

What drugs are being tested in NCT06355570?

Interventions in NCT06355570: Personal Pictures, Family Videos, Family Videos - Intervention as required.

What condition does NCT06355570 study?

NCT06355570 studies Intensive Care Unit Delirium, Cardiac Surgery, Post Operative Delirium.

Is NCT06355570 still recruiting?

NCT06355570 is currently recruiting now. Last updated 11 April 2024.

Last reviewed 2024-04-11 · How we verify

NCT06355570: DaCsi-ICU

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Delirium After Cardiac Surgery in Intensive Care Units

Recruiting now NA Last updated 11 April 2024

What this trial tests

NA trial testing Personal Pictures in Intensive Care Unit Delirium in 30 participants. Currently enrolling.

Timeline

20 March 2024

Primary endpoint
31 December 2024

20 March 2025

Quick facts

Lead sponsor	Imperial College Healthcare NHS Trust
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	basic science
Enrollment	30
Start date	20 March 2024
Primary completion	31 December 2024
Estimated completion	20 March 2025
Sites	1 location across United Kingdom

Drugs / interventions tested

Personal Pictures
Family Videos
Family Videos - Intervention as required

Conditions studied

Intensive Care Unit Delirium — all drugs for Intensive Care Unit Delirium →
Cardiac Surgery — all drugs for Cardiac Surgery →
Post Operative Delirium — all drugs for Post Operative Delirium →

Sponsor

Imperial College Healthcare NHS Trust

Who can join

18 and older, any sex, with Intensive Care Unit Delirium or Cardiac Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

STUDY SUMMARY STUDY DESIGN The study will be conducted over twelve months in the Cardiac Intensive Care Unit (ICU) at Hammersmith Hospital, Imperial College Healthcare NHS Trust (ICHT). This study is a mixed methods research design that includes the collection of data through qualitative interviews, quality-of-life questionnaires and patients' medical records. AIMS * Determine the incidence of ICU delirium in ICHT following cardiac surgery * Explore the compliance of outcome measures that diagnose ICU delirium * Implement a family-focused sensory stimulation programme in the ICU * Evaluate its useability and potential impact on patients, families and ICU staff STUDY POPULATION 30 study participants (12 patients, 12 family members/friends and 6 ICU nurses) ELIGIBILITY Study eligibility criteria are specific for each care group (patients, family members/friends and ICU nurses). DURATION 12 months at Hammersmith Hospital, ICHT

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The use of audio-visual aids to reduce delirium after cardiac surgery in intensive care units (DaCSi-ICU): A feasibility study protocol.
De Azinheira Reguenga MJ, Lampridou S, Pattison N, Brett SJ, et al · · 2025 · PMID 40273276 · DOI 10.1371/journal.pone.0320935

Verify or expand the search:

Other recruiting trials for Intensive Care Unit Delirium

Currently open trials in the same condition.

NCT07496255 — Virtual Reality Cognitive Intervention for Critically Ill Delirium Survivors (VR-Cog) · NA · recruiting
NCT06749483 — The Gut Microbiome - Source of Sepsis and Novel Target in Intensive Care Units? · recruiting
NCT05467410 — Optimal Timing of Computerized Cognitive Training for Older Intensive Care Unit Survivors · NA · active not recruiting
NCT06172491 — Automating Delirium Severity in the ICU · recruiting
NCT05950958 — Prevention of Delirium in ICU Using Multimodal Interventions · NA · recruiting

Other Imperial College Healthcare NHS Trust trials

Trials by the same sponsor.

NCT07474584 — OpRESTORE AI-Patient Navigator Study · NA · not yet recruiting
NCT07191678 — Mechanisms Affecting the Gut of Preterm Infants Receiving Blood Transfusion With Different Enteral Feed Interventions · recruiting
NCT06501846 — Pipelle® Under Ultrasound Guidance (PUG) to Investigate Post-menopausal Bleeding. · NA · recruiting
NCT04904484 — A Safety Assessment of the iZephyr Hood for NIV in COVID-19 Patients · NA · unknown
NCT05814263 — HIS Alternative II - UK Site · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06355570 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Imperial College Healthcare NHS Trust
Last refreshed: 11 April 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06355570.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing